Sequential nanotheranostics based on hollow mesoporous silica loaded doxorubicin and seed kernel extract from Mangifera indica L. as adjuvant therapy against hepatocellular carcinoma
1
Issued Date
2025-12-01
Resource Type
eISSN
15210464
Scopus ID
2-s2.0-105016773803
Pubmed ID
40984734
Journal Title
Drug Delivery
Volume
32
Issue
1
Rights Holder(s)
SCOPUS
Bibliographic Citation
Drug Delivery Vol.32 No.1 (2025) , 2559838
Suggested Citation
Sae-Be A., Leanpolchareanchai J., Plommaithong P., Chatsukit A., Ratthanakanungthum S., Wongwattanasan K., Ota T., Raowong S., Sithisarn P., Chewchinda S., Naruphontjirakul P., Termsaithong T., Sutthibutpong T., Junyaprasert V.B., Sa-Ngiamsuntorn K., Bavovada R., Pithayanukul P., Porter A.E., Ruenraroengsak P. Sequential nanotheranostics based on hollow mesoporous silica loaded doxorubicin and seed kernel extract from Mangifera indica L. as adjuvant therapy against hepatocellular carcinoma. Drug Delivery Vol.32 No.1 (2025) , 2559838. doi:10.1080/10717544.2025.2559838 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/112311
Title
Sequential nanotheranostics based on hollow mesoporous silica loaded doxorubicin and seed kernel extract from Mangifera indica L. as adjuvant therapy against hepatocellular carcinoma
Author(s)
Corresponding Author(s)
Other Contributor(s)
Abstract
Mango seed kernel extract (MSKE) and its phytochemical compositions were investigated for their anticancer activities and synergistic effects with doxorubicin (DOX) against hepatocellular carcinoma (HCC) in both 2D and 3D culture models. Molecular docking studies were conducted to elucidate the mechanisms of DOX, MSKE, and major phytochemical components against overexpressed HCC-related proteins. Co-delivery of DOX and MSKE demonstrated significant synergistic anticancer activity in both models. A sequential nanotheranostic platform (SNP), consisting of MSKE encapsulated aminated hollow mesoporous silica nanoparticles capped with graphene quantum dots (GQD-MSKE-NH2HMSNs) and DOX encapsulated HMSNs (DOX-HMSNs), was synthesized for HCC treatment. GQD conjugation allowed real-time cellular tracking and photothermal therapy (PTT). The SNP exhibited particle sizes of 96.12 ± 5.12 nm for GQD-MSKE-NH2HMSNs and 94.99 ± 6.30 nm for DOX-HMSNs, both with positive surface charges. Encapsulation efficiency (%EE) and loading capacity (%LC) of GQD-MSKE-NH2HMSNs were 95.50 ± 0.20% and 46.72 ± 1.14%, respectively, while DOX-HMSNs achieved 96.42 ± 2.48 %EE and 29.0 ± 0.70 %LC. GQD-MSKE-NH2HMSNs provided PTT and disrupted the tumor microenvironment, collagen type 1, thereby enhancing the penetration of GQD-MSKE-NH2HMSNs in 3D-HCC spheroids. In parallel, DOX-HMSNs exhibited a pH-responsive drug release behavior, allowing controlled DOX delivery in the acidic tumor area. Therefore, the SNP demonstrated significantly higher anticancer efficacy than the combination of MSKE and DOX at equivalent concentrations and provided the synergistic effect of the triple combination therapy (herbal adjuvant, PTT and chemotherapy) against HCC.